The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
This Funding Opportunity Announcement (FOA) invites applications for Clinical and Translational Science Awards (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate to the wider consortium innovative resources (to include capabilities) that have established impact at a local or national level. Applications for CTSA consortium-wide centers are expected to rapidly demonstrate and disseminate resources to advance clinical and translational science efforts.
Only applications submitted in response to a Notice of Special Interest (NOSI) published by NCATS will be allowed to apply to this FOA.
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): June 21, 2021;
June 21, 2022; June 21, 2023
PAR-21-203 Expiration Date New Date March 1, 2022 per issuance of NOT-TR-22-019(Original Date: June 22, 2023)
Areas of Interest
An application must be submitted by an institution that is a direct recipient of a CTSA Program hub or an institution listed as a partnering institution in a currently funded CTSA Program hub. A CTSA Program hub is defined as a UL1 award with a linked KL2 award and an optional TL1 award. A hub that is in no-cost extension (NCE) status is not considered a currently funded CTSA Program hub (see https://ncats.nih.gov/ctsa/about/hubs).
The PD/PI or contact PD/PI must be employed by a direct recipient of funding from a currently funded CTSA Program hub institution or a partnering institution as defined above in Eligible Organizations. Investigators who are not employed by a direct recipient of funding from a CTSA Program hub institution or partnering institution but who wish to bring an innovative project to the CTSA Program, can co-direct a project in partnership with a contact PD/PI who is employed by a currently funded CTSA Program hub institution or partnering institution using the multiple PD/PI option.
The PD/PI should be an established investigator in clinical and translational science field and capable of providing both administrative and scientific leadership to the demonstration and dissemination of the proposed activities. The PD(s)/PI(s) should have a strong track record coordinating and administrating large and collaborative networks, demonstrated experience in effectively communicating, messaging and disseminating various resources and information to stakeholders and to the broader scientific community. The PD(s)/PI(s) are each expected to commit at least two person months effort per year and preferably three to six person months per year effort to the award.
Applicants should document the PD/PI's (and, as relevant, additional senior/key personnel's) experience in 1) fulfilling the mission of the CTSA Program or another comparable program, 2) coordinating and administrating large and collaborative networks, 3) expertise and experience in the area of the described resource and/or capability, and 4) effectively communicating, messaging and successfully disseminating various resources and information to stakeholders and to the broader scientific community.
Application budgets are limited to $3,000,000 per year direct cost and must reflect the actual needs of the proposed project.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.